Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes

Details for Australian Patent Application No. 2007201180 (hide)

Owner Biosite Incorporated

Inventors Valkirs, Gunars E; Dahlen, Jeffrey R; Buechler, Kenneth F

Agent Spruson & Ferguson

Pub. Number AU-B-2007201180

Parent 2002252636

Filing date 19 March 2007

Wipo publication date 19 April 2007

Acceptance publication date 25 November 2010

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

5 April 2007 Complete Application Filed

19 April 2007 Application Open to Public Inspection

  Published as AU-B-2007201180

25 November 2010 Application Accepted

  Published as AU-B-2007201180

24 February 2011 Alteration of Name

  The name of the applicant has been altered to Alere San Diego, Inc.

24 March 2011 Standard Patent Sealed

19 April 2012 Licence Registered

  Alere San Diego, Inc. ( General Electric Capital Corporation )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007201181-Apparatus and methods for storage and release of material from tubing

2007201179-Steel suture package